Search

Your search keyword '"Salomone, Mario"' showing total 28 results
Start Over Author "Salomone, Mario" Search Limiters Full Text
28 results on '"Salomone, Mario"'

2. Under the Sign of Saint Francis: Catholics, Ethics of Responsibility, and Environmental Education

Author

Salomone, Mario

Abstract

Catholics increasingly appear to agree with the most passionate defenders of the environment. The ecological problem for Catholics is essentially moral: it comes down to respecting the value of life and the beauty of the cosmos, practicing meekness, and controlling one's desire for dominion. This point was stressed a great deal by John Paul II, who urged for an "ecological conversion" and denounced the "anthropological error" of an arbitrary use of the earth. The human responsibility also translates into educational recommendations and concrete practices: given that modern society will find no solution to the ecological problem unless it takes a serious look at lifestyle, an education in ecological responsibility becomes essential and entails a genuine conversion in thought and behaviour. (Contains 2 notes.)

Published
2006

11. Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis.

Author

Antonio Herrero, Jose, Salomone, Mario, Ramirez de Arellano, Antonio, Schaufler, Thilo, Walpen, Sebastian, and Herrero, Jose Antonio

Subjects
HEMODIALYSIS, HYPERPHOSPHATEMIA, TREATMENT of chronic kidney failure, MEDICAL care costs, MEDICAL economics
Abstract

Aims: Hyperphosphatemia is common among patients with advanced chronic kidney disease (CKD) undergoing dialysis. The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SO), has a low daily pill burden and is indicated for the control of serum phosphorus in these patients. In a retrospective database study, hemodialysis patients switched to long-term SO therapy had fewer hospitalizations compared with patients switched to other PB therapies. This economic analysis aimed to quantify potential cost-savings of reduced hospitalizations associated with SO for healthcare systems in five European countries.Materials and Methods: All-cause hospital admissions incidence data were sourced from a real-world retrospective database study comparing adult, in-center hemodialysis patients maintained on 2 years of SO therapy (mSO) versus patients who discontinued SO (dSO) within 90 days of their first prescription and switched to other PBs. A literature search was conducted to determine the cost per hospital admission for dialysis patients in the healthcare setting of each European country. A cost-model combined the incidence rate of all-cause hospital admissions and the cost per admission to estimate the country-specific inpatient costs for the mSO and dSO groups.Results: Annual inpatient cost-savings per patient in the mSO group versus the dSO group were €1,201, €2,097, €2,059, €1,512, and €3,068 in France, Germany, Italy, Spain, and the UK, respectively. When annual PB drug costs per patient were considered, the net annual economic cost-savings per patient were €327, €1,585, €1,022, €1,100, and €2,204, respectively.Limitations: Hospital admissions data used in the analysis were observational in nature and derived from a US hemodialysis patient population; the effect of SO therapy on hospitalization rates for US and European hemodialysis patients may differ. The analysis did not consider indirect healthcare costs associated with hospitalizations.Conclusion: SO therapy may offer substantial inpatient cost-savings by reducing all-cause hospital admissions attributable to uncontrolled hyperphosphatemia. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

12. 6e Congrès mondial d’éducation relative à l’environnement | Compte-rendu

Author

Salomone, Mario

Abstract

19 au 23 juillet 2011 - Brisbane, Australie Le sixième Congrès mondial d’éducation relative à l’environnement (WEEC – World Environmental Education Congress) a eu lieu à Brisbane (Australie) du 19 au 23 juillet 2011. Le congrès, qui pour la première fois avait lieu dans la région Asie-Pacifique, était co-organisé par la AAEE (Australian Association for Environmental Education) et le Secrétariat des Congrès mondiaux d’éducation relative à l’environnement. Des participants venus des cinq conti...

Published
2018

13. Nutritional treatment of advanced CKD: twenty consensus statements

Author

Cupisti, Adamasco, Brunori, Giuliano, Di Iorio, Biagio Raffaele, D'Alessandro, Claudia, Pasticci, Franca, Cosola, Carmela, Bellizzi, Vincenzo, Bolasco, Piergiorgio, Capitanini, Alessandro, Fantuzzi, Anna Laura, Gennari, Annalisa, Piccoli, Giorgina Barbara, Quintaliani, Giuseppe, Salomone, Mario, Sandrini, Massimo, Santoro, Domenico, Babini, Patrizia, Fiaccadori, Enrico, Gambaro, Giovanni, Garibotto, Giacomo, Gregorini, Mariacristina, Mandreoli, Marcora, Minutolo, Roberto, Cancarini, Giovanni, Conte, Giuseppe, Locatelli, Francesco, Gesualdo, Loreto, Gambaro, Giovanni (ORCID:0000-0001-5733-2370), Cupisti, Adamasco, Brunori, Giuliano, Di Iorio, Biagio Raffaele, D'Alessandro, Claudia, Pasticci, Franca, Cosola, Carmela, Bellizzi, Vincenzo, Bolasco, Piergiorgio, Capitanini, Alessandro, Fantuzzi, Anna Laura, Gennari, Annalisa, Piccoli, Giorgina Barbara, Quintaliani, Giuseppe, Salomone, Mario, Sandrini, Massimo, Santoro, Domenico, Babini, Patrizia, Fiaccadori, Enrico, Gambaro, Giovanni, Garibotto, Giacomo, Gregorini, Mariacristina, Mandreoli, Marcora, Minutolo, Roberto, Cancarini, Giovanni, Conte, Giuseppe, Locatelli, Francesco, Gesualdo, Loreto, and Gambaro, Giovanni (ORCID:0000-0001-5733-2370)

Abstract

The Italian nephrology has a long tradition and experience in the field of dietetic-nutritional therapy (DNT), which is an important component in the conservative management of the patient suffering from a chronic kidney disease, which precedes and integrates the pharmacological therapies. The objectives of DNT include the maintenance of an optimal nutritional status, the prevention and/or correction of signs, symptoms and complications of chronic renal failure and, possibly, the delay in starting of dialysis. The DNT includes modulation of protein intake, adequacy of caloric intake, control of sodium and potassium intake, and reduction of phosphorus intake. For all dietary-nutritional therapies, and in particular those aimed at the patient with chronic renal failure, the problem of patient adherence to the dietetic-nutritional scheme is a key element for the success and safety of the DNT and it can be favored by an interdisciplinary and multi-professional approach of information, education, dietary prescription and follow-up. This consensus document, which defines twenty essential points of the nutritional approach to patients with advanced chronic renal failure, has been written, discussed and shared by the Italian nephrologists together with representatives of dietitians (ANDID) and patients (ANED).

Published
2018

14. Elderly patients on dialysis: epidemiology of an epidemic

Author

Francesco Quarello, Pacitti A, Piccoli Giorgina Barbara, Giachino G, Salomone Mario, Magistroni Paola, Piccoli Giuseppe, and Marciello Antonio

Subjects
Adult, medicine.medical_specialty, Pediatrics, medicine.medical_treatment, Disease, Renal Dialysis, Diabetes mellitus, Epidemiology, medicine, Humans, Intensive care medicine, Dialysis, Aged, Transplantation, business.industry, Incidence, Incidence (epidemiology), Age Factors, Middle Aged, medicine.disease, Nephrology, Cohort, Kidney Failure, Chronic, Hemodialysis, business
Abstract

The increase in the incidence of elderly patients starting dialysis has been as sharp, during the 1980s-1990s, as an epidemic (+70%, +150% in different settings). According to this study, performed in Piemonte, northern Italy, the process is still ongoing. During the period 1981-93, according to the Regional Registry of Dialysis and Transplantation (RPDT: data on 100% of centres and patients), the cohort on treatment increased by 79.5% and the annual incidence by 48.3%; the increase is limited to older people and is greater in males. Nephroangiosclerosis/ischaemic renal disease and diabetes mellitus are the main diagnoses. Since the increase of elderly patients is still ongoing, forecasts are difficult; according to a computer simulation, a plateau of patients on treatment is reached only if incidence is stabilized, While it is impossible to exclude a decrease in hidden selection or an increase in referral, complex modifications at the overall population level are presumably at the basis or the increase of elderly patients on dialysis. Despite the increase in average age, however, survival improved throughout the period; this confirms the interest towards the open dialysis system adopted in Piemonte, which is characterized by easy shifts among treatments and by the widespread use of high tolerance techniques.

Published
1996
Full Text
View/download PDF

15. Partecipazione, reti, partenariato: quale eredità per il decennio

Author

Salomone, Mario

Subjects
Settore SPS/10 - Sociologia dell'Ambiente e del Territorio, environmental education, network, participation, partnership, sustainability, partenariato, sostenibilità, reti, partecipazione, educazione ambientale
Published
2011

17. Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial.

Author

Saglimbene, Valeria, Palmer, Suetonia C., Craig, Jonathan C., Ruospo, Marinella, Nicolucci, Antonio, Tonelli, Marcello, Johnson, David, Lucisano, Giuseppe, Williams, Gabrielle, Valentini, Miriam, D’Alonzo, Daniela, Pellegrini, Fabio, Strippoli, Paolo, Salomone, Mario, Santoro, Antonio, Maffei, Stefano, Hegbrant, Jörgen, Tognoni, Gianni, Strippoli, Giovanni F. M., and null, null

Subjects
ANEMIA treatment, HEMODIALYSIS, ERYTHROPOIESIS, HEMOGLOBINS, ADVERSE health care events, RANDOMIZED controlled trials
Abstract

The increased risks of death and adverse events with erythropoiesis-stimulating agent (ESA) therapy targeting a higher hemoglobin level are established. It is uncertain whether the adverse effects of ESA therapy are related to dose and are mitigated when a fixed low ESA dose is used. We conducted a multicenter, prospective randomized open-label, blinded-endpoint (PROBE) trial to evaluate fixed low versus high dose ESA therapy on patient outcomes. We intended to recruit 2104 hemodialysis patients >18 years with anemia or receiving ESA treated at dialysis clinics in Italy. The intervention was fixed low (4000 IU epoetin alfa equivalent weekly) or high (18,000 IU epoetin alfa equivalent weekly) dose ESA for 12 months. Primary outcomes were serum transferrin, ferritin, albumin, C-reactive protein and ESA dose. Secondary outcomes were the composite of death or cardiovascular event, all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, cardiovascular hospitalization, and quality of life. Study recruitment was terminated after inclusion of 656 participants with convergence of ESA dose between groups during follow up. Fixed low dose ESA had uncertain effects on serum ferritin (delta of delta (DD) 3.9 ng/ml, 95% CI -85.0 to 92.8), transferrin (9.2 mg/dl, -6.3 to 24.8), transferrin saturation (3.7%, -5.0 to 12.3), serum albumin (-0.03 g/dl, -0.2 to 0.1), or C-reactive protein (-0.6 mg/l, -3.3 to 2.1). In addition, fixed dose therapy had inconclusive effects on the composite endpoint of mortality and cardiovascular events (hazard ratio [HR] 0.95, 95% CI 0.66 to 1.37), death (0.98, 0.64 to 1.52), nonfatal myocardial infarction (0.52, 0.18 to 1.52), nonfatal stroke (no events), hospital admission for cardiovascular causes (0.93, 0.50 to 1.72) or health-related quality of life. A fixed low ESA dose in hemodialysis patients has uncertain effects on serum parameters, mortality, cardiovascular events, and quality of life. Hemoglobin targets may be so entrenched in nephrology practice that a trial of ESA dose is no longer possible. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

18. Dialisi peritoneale e strategie per la diffusione: le strade del Piemonte; analisi critica dei risultati e apertura di nuovi fronti di intervento

Author

Iadarola, Gian Maria, Salomone, Mario, Maffei, Stefano, Neri, Loris, Iadarola, Gian Maria, Salomone, Mario, Maffei, Stefano, and Neri, Loris

Abstract

Si ritiene che il ben noto fenomeno della progressiva diminuzione dei pazienti (pz) sottoposti a emodialisi (HDD) o a dialisi peritoneale (DP) domiciliare sia determinato da età avanzata dei pz incidenti, comorbidità, solitudine e presenza di ostacoli culturali e organizzativi. Un provvedimento approvato dalla Regione Piemonte (DGR 8–12316, del 12 Ottobre del 2009) stabilisce un contributo finanziario a sostegno della dialisi domiciliare (HD-Dom), la cui entità deriva da un sistema di valutazione a punti (Piano Assistenziale Individuale Dialisi Domiciliare, P.A.I.D.D.), che valuta la ridotta autonomia del pz nel gestire il trattamento. Il punteggio finale definisce l'intensità della necessità assistenziale e, quindi, il sostegno finanziario calcolato anche in base al tipo di trattamento e alla tipologia del caregiver. Al termine del primo triennio, il numero dei pz della popolazione totale in trattamento dialitico in Regione era stabile; incidenza e prevalenza dei pz HDDom sono aumentate nel 2010 e risultano stabili nel 2011–2012. È verosimile che il provvedimento si sia dimostrato efficace nell'invertire la tendenza di incidenza e prevalenza dei pz HDDom: lo stesso si rivela essere uno strumento potente, ma non sufficiente di per sé. In Piemonte, attualmente, sono allo studio altre soluzioni per integrare il provvedimento, al fine di agevolare la soluzione di altri problemi, tra cui la scarsa motivazione dei nefrologi, i pregiudizi e la mancanza di conoscenza e di preparazione culturale in merito alla dialisi domiciliare., The well-known phenomenon of gradual reduction of patients undergoing haemodialysis (HDD) or peritoneal dialysis (PD) treatment at home seems to be caused by aging of incident patients, comorbilities, loneliness, and the presence of cultural and organizational obstacles. A measure approved by the Piedmont region (D.G.R. 8–12316 - October 12, 2009) provides a financial contribution supporting home dialysis (HoD). The amount of the contribution depends on a scoring system (Home Dialysis Assistance Plan - P.A.I.D.D.) assessing each patient for his lack of independence in managing the treatment. The final score identifies the patients' assistance needs and, thus, the amount of financial support, also according to the type of treatment and caregiver. At the end of the first 3-year period of use of the measure, the overall population on dialysis was stable; incidence and prevalence of HoD patients increased in 2010 and remained stable in the period 2011–2012. It is possible that this measure can effectively reverse the incidence and prevalence trend of HoD patients: in fact, it turned out to be a potentially powerful tool, despite not being sufficient by itself. Analysis of further means to integrate this measure are currently undergoing in Piedmont, in order to facilitate the solution of other problems, including the poor motivation of nefrologists, prejudice, and the lack of knowledge and background on the issue of home dialysis.

Published
2014

19. Peritoneal Dialysis and Strategies for its Diffusion: The Solutions of Piedmont Region; Critical Analysis of the Results and New Frontiers

Author

Iadarola, Gian Maria, Salomone, Mario, Maffei, Stefano, Neri, Loris, Iadarola, Gian Maria, Salomone, Mario, Maffei, Stefano, and Neri, Loris

Abstract

The well-known phenomenon of gradual reduction of patients undergoing haemodialysis (HDD) or peritoneal dialysis (PD) treatment at home seems to be caused by aging of incident patients, comorbilities, loneliness, and the presence of cultural and organizational obstacles. A measure approved by the Piedmont region (D.G.R. 8–12316 - October 12, 2009) provides a financial contribution supporting home dialysis (HoD). The amount of the contribution depends on a scoring system (Home Dialysis Assistance Plan - P.A.I.D.D.) assessing each patient for his lack of independence in managing the treatment. The final score identifies the patients' assistance needs and, thus, the amount of financial support, also according to the type of treatment and caregiver. At the end of the first 3-year period of use of the measure, the overall population on dialysis was stable; incidence and prevalence of HoD patients increased in 2010 and remained stable in the period 2011–2012. It is possible that this measure can effectively reverse the incidence and prevalence trend of HoD patients: in fact, it turned out to be a potentially powerful tool, despite not being sufficient by itself. Analysis of further means to integrate this measure are currently undergoing in Piedmont, in order to facilitate the solution of other problems, including the poor motivation of nefrologists, prejudice, and the lack of knowledge and background on the issue of home dialysis., Si ritiene che il ben noto fenomeno della progressiva diminuzione dei pazienti (pz) sottoposti a emodialisi (HDD) o a dialisi peritoneale (DP) domiciliare sia determinato da età avanzata dei pz incidenti, comorbidità, solitudine e presenza di ostacoli culturali e organizzativi. Un provvedimento approvato dalla Regione Piemonte (DGR 8–12316, del 12 Ottobre del 2009) stabilisce un contributo finanziario a sostegno della dialisi domiciliare (HD-Dom), la cui entità deriva da un sistema di valutazione a punti (Piano Assistenziale Individuale Dialisi Domiciliare, P.A.I.D.D.), che valuta la ridotta autonomia del pz nel gestire il trattamento. Il punteggio finale definisce l'intensità della necessità assistenziale e, quindi, il sostegno finanziario calcolato anche in base al tipo di trattamento e alla tipologia del caregiver. Al termine del primo triennio, il numero dei pz della popolazione totale in trattamento dialitico in Regione era stabile; incidenza e prevalenza dei pz HDDom sono aumentate nel 2010 e risultano stabili nel 2011–2012. È verosimile che il provvedimento si sia dimostrato efficace nell'invertire la tendenza di incidenza e prevalenza dei pz HDDom: lo stesso si rivela essere uno strumento potente, ma non sufficiente di per sé. In Piemonte, attualmente, sono allo studio altre soluzioni per integrare il provvedimento, al fine di agevolare la soluzione di altri problemi, tra cui la scarsa motivazione dei nefrologi, i pregiudizi e la mancanza di conoscenza e di preparazione culturale in merito alla dialisi domiciliare.

Published
2014

26. Steroid and cyclophosphamide in IgA nephropathy

Author

Roccatello, Dario, primary, Ferro, Michela, additional, Cesano, Giulio, additional, Rossi, Daniela, additional, Berutti, Silvia, additional, Salomone, Mario, additional, Piccoli, Giuseppe, additional, and Sena, Luigi Massimino, additional

Published
2000
Full Text
View/download PDF

27. AISF position paper on HCV in immunocompromised patients

Author

Gabriele Missale, Mauro Viganò, Marco Astegiano, Mauro Salizzoni, C. Chialà, Angelo Pera, Patrizia Racca, Massimo Di Maio, Mario Salomone, M. Puoti, Simone Parisi, Paolo Bironzo, M. Rendina, Carla Pasquina, Clodoveo Ferri, Luisa Pasulo, Rita Tozzi, A. Tucci, Pietro Lampertico, Emanuele Angelucci, Bruno Daniele, Patrizia Burra, Franco Riccardini, Marco Lagget, Fabio Salvatore Macaluso, Davide Giuseppe Ribaldone, Luca Miele, Clara Lisa Peroni, Raffaele Bruno, Anna Linda Zignego, Ambrogio Orlando, Giovanni Battista Gaeta, Giuseppe Montrucchio, Daniela Libertucci, Massimo Marignani, Agostino Colli, Enrico Fusaro, Antonio Craxì, Giorgio Maria Saracco, Barbara Imperatrice, Paolo Caraceni, Luisa Giaccone, Chiara Baratelli, Giuliano Torre, Luigi Biancone, Elisabetta De Gasperi, Mario Rizzetto, Maria Grazia Clemente, Francesco Paolo Russo, Aldo Giacardi, Riccardo Volpes, Edoardo G. Giannini, Daniele Curci, Rossella Della Valle, Salvatore Petta, Pierluigi Toniutto, Alessandro Busca, Pietro Vajro, Giorgio Verme, Chiara Mazzarelli, Paolo Grossi, Maria Chiara Ditto, Lorella Orsucci, Umberto Vitolo, Alberto Mella, Salvatore Madonia, Federica Cavallo, Maria Giuseppina Cabras, Stefano Bonora, Massimiliano Conforti, Vito Di Marco, Mario Pirisi, Giuseppe Cariti, Marta Coscia, Giuseppina Brancaccio, L. Scaglione, Stefano Fagiuoli, Alfredo Marzano, Stefano Cusinato, Roberto Minutolo, Giuseppe Rossi, Enrico Brignardello, Maurizia Rossana Brunetto, Marzano A., Angelucci E., Astegiano M., Baratelli C., Biancone L., Bironzo P., Brancaccio G., Brunetto M.R., Bruno R., Burra P., Cabras M.G., Caraceni P., Chiala C., Clemente M.G., Colli A., Daniele B., De Gasperi E., Di Marco V., Ditto M.C., Fagiuoli S., Ferri C., Gaeta G.B., Grossi P.A., Imperatrice B., Lampertico P., Macaluso F.S., Madonia S., Marignani M., Mazzarelli C., Mella A., Missale G., Parisi S., Pasulo L., Puoti M., Rendina M., Ribaldone D., Rossi G., Toniutto P., Tucci A., Vajro P., Vigano M., Volpes R., Zignego A.L., Giannini E.G., Miele L., Russo F.P., Petta S., Bonora S., Brignardello E., Busca A., Cariti G., Cavallo F., Conforti M., Coscia M., Craxi A., Curci D., Cusinato S., Di Maio M., Valle R.D., Fusaro E., Giacardi A., Giaccone L., Lagget M., Libertucci D., Minutolo R., Montrucchio G., Orlando A., Orsucci L., Pasquina C., Pera A., Peroni C.L., Pirisi M., Racca P., Riccardini F., Rizzetto M., Salizzoni M., Salomone M., Saracco G.M., Scaglione L., Torre G., Tozzi R., Vitolo U., Verme G., Angelucci, E, Astegiano, M, Baratelli, C, Biancone, L, Bironzo, P, Brancaccio, G, Brunetto, M, Bruno, R, Burra, P, Cabras, M, l Caraceni, P, Chialà, C, Clemente, M, Colli, A, Daniele, B, De Gasperi, E, Di Marco, V, Ditto, M, Fagiuoli, S, Ferri, C, Gaeta, G, Grossi, P, Imperatrice, B, Lampertico, P, Macaluso, F, Madonia, S, Marignani, M, Mazzarelli, C, Mella, A, Missale, G, Parisi, S, Pasulo, L, Puoti, M, Rendina, M, Ribaldone, D, Rossi, G, Toniutto, P, Tucci, A, Vajro, P, Viganò, M, Volpes, R, Zignego, A, Giannini, E, Miele, L, Russo, F, Petta, S, Bonora, S, Brignardello, E, Busca, A, Cariti, G, Cavallo, F, Conforti, M, Coscia, M, Craxì, A, Curci, D, Cusinato, S, Di Maio, M, Valle, R, Fusaro, E, Giacardi, A, Giaccone, L, Lagget, M, Libertucci, D, Minutolo, R, Montrucchio, G, Orlando, A, Orsucci, L, Pasquina, C, Pera, A, Peroni, C, Pirisi, M, Racca, P, Riccardini, F, Rizzetto, M, Salizzoni, M, Salomone, M, Saracco, G, Scaglione, L, Torre, G, Tozzi, R, Vitolo, U, Verme, G, Marzano, Alfredo, Angelucci, Emanuele, Astegiano, Marco, Baratelli, Chiara, Biancone, Luigi, Bironzo, Paolo, Brancaccio, Giuseppina, Brunetto, Maurizia Rossana, Bruno, Raffaele, Burra, Patrizia, Cabras, Maria Giuseppina, Caraceni, Paolo, Chialà, Claudia, Clemente, Maria Grazia, Colli, Agostino, Daniele, Bruno, De Gasperi, Elisabetta, Di Marco, Vito, Ditto, Maria Chiara, Fagiuoli, Stefano, Ferri, Clodoveo, Gaeta, Giovanni Battista, Grossi, Paolo Antonio, Imperatrice, Barbara, Lampertico, Pietro, Macaluso, Fabio Salvatore, Madonia, Salvatore, Marignani, Massimo, Mazzarelli, Chiara, Mella, Alberto, Missale, Gabriele, Parisi, Simone, Pasulo, Luisa, Puoti, Massimo, Rendina, Maria, Ribaldone, Davide, Rossi, Giuseppe, Toniutto, Pierluigi, Tucci, Alessandra, Vajro, Pietro, Viganò, Mauro, Volpes, Riccardo, Zignego, Anna Linda, Giannini, Edoardo G., Miele, Luca, Russo, Francesco Paolo, Petta, Salvatore, Bonora, Stefano, Brignardello, Enrico, Busca, Alessandro, Cariti, Giuseppe, Cavallo, Federica, Conforti, Massimiliano, Coscia, Marta, Craxì, Antonio, Curci, Daniele, Cusinato, Stefano, Di Maio, Massimo, Valle, Rossella Della, Fusaro, Enrico, Giacardi, Aldo, Giaccone, Luisa, Lagget, Marco, Libertucci, Daniela, Minutolo, Roberto, Montrucchio, Giuseppe, Orlando, Ambrogio, Orsucci, Lorella, Pasquina, Carla, Pera, Angelo, Peroni, Clara Lisa, Pirisi, Mario, Racca, Patrizia, Riccardini, Franco, Rizzetto, Mario, Salizzoni, Mauro, Salomone, Mario, Saracco, Giorgio Maria, Scaglione, Luca, Torre, Giuliano, Tozzi, Rita, Vitolo, Umberto, Verme, Giorgio, and Ditto, MARIA CHIARA

Subjects
medicine.medical_specialty, Transplant Recipient, Comorbidity, Antiviral Agents, Organ transplantation, 03 medical and health sciences, Immunocompromised Host, 0302 clinical medicine, Internal medicine, Neoplasms, medicine, Immunocompromised patient, Humans, Chronic, Intensive care medicine, Antiviral Agent, Hepatology, business.industry, Gastroenterology, Hepatitis C, Chronic, medicine.disease, Hepatitis C, Organ transplant, HCV, Immunocompromised patients, Transplant Recipients, Immunocompetence, Italy, 030220 oncology & carcinogenesis, HCV, Immunocompromised patients, Organ transplant, Position paper, Neoplasm, 030211 gastroenterology & hepatology, business, Direct acting, Human
Abstract

This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

Published
2018

28. Nutritional treatment of advanced CKD: twenty consensus statements

Author

Francesco Locatelli, Massimo Sandrini, Franca Pasticci, Loreto Gesualdo, Alessandro Capitanini, Mario Salomone, Giacomo Garibotto, Roberto Minutolo, Patrizia Babini, Enrico Fiaccadori, Giovanni Gambaro, Giuliano Brunori, Giorgina B Piccoli, Claudia D’Alessandro, Giuseppe Conte, Vincenzo Bellizzi, Annalisa Gennari, Giovanni Cancarini, Adamasco Cupisti, Anna Laura Fantuzzi, Carmela Cosola, Domenico Santoro, Biagio Di Iorio, Piergiorgio Bolasco, Giuseppe Quintaliani, Marcora Mandreoli, Mariacristina Gregorini, Cupisti, Adamasco, Brunori, Giuliano, Di Iorio, Biagio Raffaele, D’Alessandro, Claudia, Pasticci, Franca, Cosola, Carmela, Bellizzi, Vincenzo, Bolasco, Piergiorgio, Capitanini, Alessandro, Fantuzzi, Anna Laura, Gennari, Annalisa, Piccoli, Giorgina Barbara, Quintaliani, Giuseppe, Salomone, Mario, Sandrini, Massimo, Santoro, Domenico, Babini, Patrizia, Fiaccadori, Enrico, Gambaro, Giovanni, Garibotto, Giacomo, Gregorini, Mariacristina, Mandreoli, Marcora, Minutolo, Roberto, Cancarini, Giovanni, Conte, Giuseppe, Locatelli, Francesco, and Gesualdo, Loreto

Subjects
Nephrology, Dietary Fiber, Potassium intake, medicine.medical_treatment, 030232 urology & nephrology, Chronic renal failure, CKD, Dialysis, Diet, Kidney transplant, Nutritional treatment, Consensus, Contraindications, Dietary Proteins, Dietary Supplements, Dysbiosis, Humans, Nutrition Assessment, Patient Care Team, Patient Compliance, Patient Education as Topic, Phosphorus, Dietary, Renal Insufficiency, Chronic, Renal Replacement Therapy, Sodium, Dietary, Energy Intake, 030204 cardiovascular system & hematology, 0302 clinical medicine, Medicine, Renal Insufficiency, Chronic, Dialysi, Phosphorus, medicine.medical_specialty, MEDLINE, Dietary, 03 medical and health sciences, Internal medicine, Renal replacement therapy, Medical prescription, Position papers and Guidelines, Intensive care medicine, business.industry, Sodium, medicine.disease, business, Kidney disease
Abstract

The Italian nephrology has a long tradition and experience in the field of dietetic-nutritional therapy (DNT), which is an important component in the conservative management of the patient suffering from a chronic kidney disease, which precedes and integrates the pharmacological therapies. The objectives of DNT include the maintenance of an optimal nutritional status, the prevention and/or correction of signs, symptoms and complications of chronic renal failure and, possibly, the delay in starting of dialysis. The DNT includes modulation of protein intake, adequacy of caloric intake, control of sodium and potassium intake, and reduction of phosphorus intake. For all dietary-nutritional therapies, and in particular those aimed at the patient with chronic renal failure, the problem of patient adherence to the dietetic-nutritional scheme is a key element for the success and safety of the DNT and it can be favored by an interdisciplinary and multi-professional approach of information, education, dietary prescription and follow-up. This consensus document, which defines twenty essential points of the nutritional approach to patients with advanced chronic renal failure, has been written, discussed and shared by the Italian nephrologists together with representatives of dietitians (ANDID) and patients (ANED).

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results